Based on both peptide-spectra matches (PSMs) and glycoPSMs, MPO emerged as the most abundant glycoprotein, particularly in more aggressive stages of bladder cancer (T1 and MIBC). The gene discussed is MPO; the disease is urinary bladder carcinoma.